Sierra Capital’s Pacira BioSciences PCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$313K Hold
12,500
– – 0.03% 189
2026
Q2
$317K Hold
12,500
– – 0.03% 193
2026
Q1
$283K Hold
12,500
– – 0.03% 194
2025
Q4
$324K Hold
12,500
– – 0.03% 174
2025
Q3
$322K Hold
12,500
– – 0.04% 187
2025
Q2
$299K Buy
+12,500
New +$315K 0.03% 188

Other funds holding PCRX

Sierra Capital's PCRX Position: Q3 2026 in Review

Sierra Capital held its Pacira BioSciences (PCRX) position steady in Q3 2026 at 12,500 shares worth $313K. The position accounts for 0.03% of the portfolio, ranked #189.

Sierra Capital first reported a position in PCRX in Q2 2025 and has held it in 6 quarters since. The position peaked at $324K in Q4 2025. 257 funds tracked by Wall St. Rank hold PCRX as of Q3 2026.

  • Sierra Capital held 12,500 shares of Pacira BioSciences worth $313K as of Q3 2026.
  • Sierra Capital left its Pacira BioSciences share count unchanged in Q3 2026.
  • Pacira BioSciences made up 0.03% of Sierra Capital's portfolio in Q3 2026, its #189 holding.
  • Sierra Capital first reported a position in Pacira BioSciences in Q2 2025 and has held it in 6 quarters since.
  • Sierra Capital's Pacira BioSciences position peaked at $324K in Q4 2025.
  • 257 funds tracked by Wall St. Rank held Pacira BioSciences as of Q3 2026.

Based on Sierra Capital's 13F filing for Q3 2026, filed 16 Nov 2026.